INTRODUCTION
Viruses employ various strategies to counteract host cell defence systems. One of these strategies involves reorganization of the cell cytoskeleton [1] [2] [3] [4] [5] . The microtubule (MT) cytoskeleton is a highly dynamic system composed of ordered arrays of alpha-and beta-tubulin molecules. MTs support vital cell functions, including motility, morphogenesis, cytoplasmic transport, and mitosis [6] . The properties of MTs depend on the involved tubulin subunits (which may be posttranslationally modified in different ways) as well as on interactions with motor and MT-associated proteins (MAPs) [7] . It is noteworthy that the cell possesses "quality control" machinery composed of several check points along tubulin biogenesis and degradation pathways that ensures appropriate functions of MTs [8] . It has long been known that viruses exploit host MT networks for their intracellular trafficking to sites of replication, assembly and egress [9, 10] . Furthermore, it is becoming increasingly evident that viruses reorganize the MT cytoskeleton in order to adapt it for the needs of their replication and to suppress the cellular defence systems [11] . Our previous results suggest that reduction of the MT cytoskeleton dynamics, which appears to be inherent for LLC-MK2 cells, interferes with infection of these cells by human influenza A/NWS/33 virus, thus making them semi-permissive for A/NWS/33 [12] . Indirect evidence suggests that viral haemagglutinin becomes trapped on stable MT cytoskeleton. Thus, mobilization of the MT cytoskeleton may facilitate viral infection. Indeed, in another model, it has been reported that HIV tat protein triggers mobilization of the MT cytoskeleton by inducing proteasome-mediated MAP2 degradation in neuronal cells [13] . Our own observations demonstrate that upon infection of LLC-MK2 cells by influenza A/NWS/33 virus the level of MAP4 decreases [12] . It was thus reasonable to propose that influenza A virus may trigger proteasome-mediated proteolytic events in LLC-MK2 cells in order to increase MT dynamics, which favour viral replication. The involvement of the ubiquitinproteasomal protein degradation system (UPS) in viral replication processes has been documented [14] [15] [16] [17] . Importantly, specific viral proteins are able to interact with proteasomes to control their proteolytic functions [18] [19] [20] . Specifically, influenza viruses exploit the ubiquitin/vacuolar protein sorting pathway for efficient internalization into host cells [21] . Therefore, proteasome inhibition affects influenza virus entry at a post-fusion step, causing the cytosolic retention of the viral nucleoprotein [22] . It should be mentioned that the UPS is involved in the control of various cellular processes including cell cycle progression, signal transduction, DNA repair, and gene expression [23] [24] [25] . Here we were interested in later steps of development of the influenza A (H1N1) virus infectious cycle, and we analysed how these steps could be influenced by chemical suppression of proteasome activity. Our results demonstrate that administration of proteasome inhibitor interferes with influenza A virus infection-dependent destabilization of the MT cytoskeleton in semi-permissive LLC-MK2 cells. Although the precise targets of proteasome degradation in infected cells remain to be identified, indirect evidence suggests that these targets include acetylated tubulin and/or enzymes and regulatory systems involved in control of the equilibrium between acetylated and non-acetylated tubulin.
MATERIALS AND METHODS

Cells and viruses
Human type II alveolar epithelial (A549, TCL 101), rhesus monkey-kidney (LLC-MK2, BS CL57) and Madin-Darby canine-kidney (MDCK, BS CL 64) cell lines were purchased from "Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna" (Brescia, Italy). Cells were cultured in F12/HAM's (A549) or E-MEM (LLC-MK2 and MDCK) media supplemented with 2 mM L-glutamine, 10% (v/v) bovine fetal serum and antibiotics. Cells were maintained at 37°C in a 5% CO 2 atmosphere. Culture reagents were from PAAThe cell culture company. Human A/NWS/33 (A/NWS/33, ATCC VR 219) and avian A/Mallard/Italy/303394-11/03 (A/Mallard/03, provided by "Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna", Brescia, Italy) influenza viruses (subtype H1N1) were propagated as previously detailed [12, 26, 27] . Cells grown to confluence in shell vials or 6-well plates were infected at a multiplicity of infection (MOI) of either 0.01 or 0.1 plaque forming units (PFU)/cell to better evidence the host cell-dependent susceptibility to virus infection. Alternatively, an MOI of either 1 or 2 PFU/cell was employed in order to assess specific features of the infectious process. After absorption for 75 min at 4°C, the viral inoculum was removed and cells were incubated for the planned time. 
Drugs
The peptide aldehyde Z-Leu-Leu-Leu-al (MG132) substrate analogue, inhibiting primarily the chymotrypsin-like activity of the 26S proteasome, was applied at 2 or 8 μM. Cells were mock-infected or infected for the planned time in the absence of MG132. At 4 h post-infection (p.i.) the drug was added to cell monolayers without further removal. The small molecule 1-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-pyrrolidin-1-yl-ethanone (IU1), inhibiting the deubiquitinating enzyme USP14, was applied at 50 μM for 4-8 h, according to previous data [28] . Upon IU1 removal, cells were mock-infected or infected for the planned time. The proteasome modulators MG132 and IU1 were reconstituted and stored according to the manufacturers' instructions, and used with matching concentrations of the vehicle in the cell control. The highest applicable concentration and maximum treatment time were assessed by 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) and trypan blue staining in order to avoid toxic effects and guarantee fully viable cells. Drugs and chemicals were from Sigma-Aldrich.
Trypan blue assay
To determine cell vitality, trypan blue exclusion assay was used. The cells were trypsinized and washed in PBS, followed by centrifugation at 2,500 x g for 5 min. The cell pellet was resuspended in 0.4% trypan blue in phosphate-buffered saline (PBS; pH 7.4) (7 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 137 mM NaCl, 2.7 mM KCl) and incubated for 10 min at room temperature. The viable cells were scored with a haemocytometer through the exclusion of trypan blue. To evaluate cell morphology, cell monolayers were first overlaid with 0.4% trypan blue solution for 10 min and then washed in PBS before observation with an inverted microscope (Carl-Zeiss).
Staining of nuclei with DAPI
For the assessment of apoptosis, morphological changes of nuclei were visualized following DNA staining by DAPI. The cells were fixed with chilled methanol for 10 min at -20°C and washed in PBS, before staining with 2.5 μg/ml DAPI solution for 45 min at 37°C. The cells were then washed twice with PBS, mounted in buffered glycerol solution (Argene) and analysed through an epifluorescence microscope (DMLB Leica).
Indirect immunofluorescence assay
Cells were fixed as previously detailed [12] . Primary antibodies were applied for 1 h at 37°C. Next, the cells were washed in PBS, and secondary antibodies applied for 45 min at 37°C. For negative controls, primary antibodies were replaced by 0.2% (w/v) bovine serum albumin (BSA) in PBS. Finally, cells were mounted in buffered glycerol solution (Argene) and analysed through an epifluorescence microscope (DMLB Leica). For NP fluorescence quantization, ten randomly selected fields per cell monolayer were analysed, and NP-positive cells expressed as mean percentage values of the total cell number per field, estimated by chromatin staining with DAPI. Immunofluorescence assays were performed three times in two replicate shell vials for each experimental condition.
Fifty percent tissue culture infectious dose (TCID 50 ) assay
To evaluate viral yields from culture supernatants, TCID 50 assays were performed three times for each experimental condition, by using MDCK cell monolayers, as previously detailed [12] .
Microtubule polymerization assay
The MT polymerization assay was carried out as previously described [29] , with a few modifications. Briefly, LLC-MK2 cells grown in 6-well plates were either MG132-treated or mock-treated for 3 h or 18 h, respectively. Cell lysates were collected with a scraper in PBS and centrifuged at 4,000 x g for 10 min at 37°C. The obtained pellets were homogenized in 100 μl of lysis buffer (10 μM paclitaxel, 1 mM MgCl 2 , 2 mM EGTA, 0.5% v/v Nonidet P-40, 20 mM Tris-HCl, pH 6.8, and protease inhibitors) for 15 min and, after that, vortexed. The samples were then centrifuged at 15,000 x g for 10 min at 37°C to separate the polymerized (pellet) from the soluble (supernatant) fraction of MTs. Next, the pellets were homogenized by sonication in a volume of lysis buffer equivalent to that of the soluble fraction. Finally, samples were treated with Laemmli buffer (25% v/v glycerol, 0.1% w/v bromophenol blue, 2% w/v sodium dodecyl sulphate (SDS), 100 mM dithiothreitol, 50 mM Tris-HCl, pH 6.8) before Western blotting assays. MT polymerization assays were performed three times with cell lysates collected from two replicate wells for each experimental condition.
Western blotting assay
Cells were mock-infected or influenza A virus-infected in the presence or absence of pharmacological proteasome modulators. Next, cell lysates were collected as previously described [26] . Equal amounts of proteins (30 μg/lane) were resolved by SDS-8% (w/v) (MAP4) or -12.5% (w/v) (acetylated alpha-tubulin and GAPDH) polyacrylamide gel electrophoresis (PAGE), and then transferred onto nitrocellulose membranes. Following a blocking step in non-fat dry milk for 1 h at room temperature, the membranes were incubated for 1 h 30 min in non-fat dry milk with primary antibodies. After washing in PBS, the membranes were incubated for 1 h in PBS containing AP-conjugated antibodies. Thereafter, the membranes were washed in PBS and bound antibodies detected with 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium buffered substrate (Sigma-Aldrich). Quantitative analysis of protein expression was performed by scanning densitometry on the Bio-Rad's GEL DOC XR system using the Quantity One software. Western blotting assays were performed three times with cell lysates collected from two replicate wells for each experimental condition.
Confocal microscopy and image analysis
The subcellular localization of viral NP, 20S proteasomes and markers for stabilized MTs was investigated using a Zeiss LSM 510 Meta inverted confocal microscope with a 63x NA 1.4 plan apo objective. The data were obtained from two independent reproducible experiments performed in two replicate shell vials. Green and red fluorescent dyes were excited with the 488 nm argon and 543 nm He-Ne laser lines, respectively. Acquisitions were obtained in the multitrack mode, with the relevant beamsplitters; barrier filters were 505-530 nm and 560-615 nm band pass. Each image was the result of the averaging of two scans of each line to reduce noise. Negative controls were examined in parallel to assess the specificity of the signals and absence of any background. No mutual cross-talking of the two signals was detectable. Series of x-y sections were acquired, with an optimal z-step, to cover the whole height of the samples. For analysis of co-localization, a scatter diagram of the number of red pixels against the number of green pixels was generated from each merged image. The weighted co-localization coefficients represent the sum of intensity of co-localizing pixels in red and green channels as compared to the overall sum of pixel intensity above the threshold. The weighted coefficient could be 0 (no co-localization) or 1 (all pixels co-localize). Bright pixels contribute more than faint pixels. The profile display mode was used for the intensity profile graphs.
Statistical analysis
The differences between results of various experiments were evaluated by twotailed Student's t-test. The error bars in the graphs show standard deviations. Statistical analyses were performed with GraphPad Prism (version 5.0 for Windows). A P value < 0.005 was considered as strongly statistically significant, a P value < 0.05 as statistically significant, and a P value > 0.05 as statistically non-significant.
RESULTS
Proteasome inhibition with MG132 raises the extent of tubulin acetylation in LLC-MK2 cells
In the first set of experiments we investigated whether suppression of proteasome activity by MG132 influences the properties of the MT cytoskeleton in LLC-MK2 cells. With this aim the characteristics of MT cytoskeleton in control cells and cells cultivated in the medium containing MG132 for 3 h or 18 h were compared using MT polymerization assay and Western blotting analysis of acetylated alpha-tubulin and MAP4. These two proteins were chosen because both contribute to MT stabilization [30] [31] [32] 4) or MG132-treated (lanes 2, 5: 2 μM; lanes 3, 6: 8 μM) for 3 h (A-C) or 18 h (A'-C'), respectively. Cell lysates were then subjected to MT polymerization assays and divided into polymerized (P) and soluble (S) fractions. Equal amounts of proteins were separated by SDS-PAGE and afterwards probed by immunoblotting with antiacetylated alpha-tubulin (A, A') and anti-MAP4 (B, B') antibodies. C, C' -The presence of GAPDH was checked as a protein loading control. D, D' -Relative intensity values from three independent experiments repeated in two replicate wells were normalized to GAPDH, except for acetylated alpha-tubulin in S fractions, and then analysed regarding density differences with corresponding control samples. Error bars in graphs represent standard deviations. ** P < 0.005, * P < 0.05, and not statistically significant (n.s.) P > 0.05 vs the corresponding control groups, as determined by two-tailed Student's t-test.
containing MG132 did not influence the level of acetylated alpha-tubulin (compare lanes 2 and 3 in Fig. 1A vs lanes 2 and 3 in Fig. 1A') . The relative levels of MAP4 were less influenced by MG132. The major portion of this protein was associated with pelleted (polymerized) MTs. However, it was also present in the soluble fraction. We evidenced a small (although statistically significant) decrease of the relative level of MAP4 associated with polymerized MTs in cells treated with MG132, which in three out of four time/dose conditions of MG132 treatment correlated with the similarly small increase of the relative level of MAP4 in the soluble fraction (lanes 2 and 3 vs lane 1 and lanes 5 and 6 vs lane 4 in Fig. 1B and B' ). Collectively, the results presented in this section suggest that long-time inhibition of proteasome activity causes additional stabilization of the polymerized MT cytoskeleton.
Late phases of influenza A (H1N1) virus replication in LLC-MK2 and A549 cells are sensitive to proteasome inhibition with MG132
It has been previously reported that early stages of influenza A/WSN/33 (H1N1) virus infection are very sensitive to proteasome inhibitors [21, 22] . The suppression of influenza virus infection in this case cannot be, however, explained by stabilization of the MT cytoskeleton. Indeed, in the abovedescribed experiments (see the previous section) we demonstrated that incubation of LLC-MK2 cells with MG132 for 3 h does not affect the properties of the MT cytoskeleton. Being interested in the role of the cytoskeleton in suppression of influenza A/NWS/33 virus infection, we investigated how longterm exposure to MG132 of already infected cells influences the later stages of the viral infectious process. To better understand the possible impact of proteasome inhibitors on the integrity and/or dynamics of the MT cytoskeleton, we studied in parallel two cellular models, namely LLC-MK2 and A549 cells, which differ in the stability/dynamics of the MT cytoskeleton [12, 33, 34] . In order to evaluate the effects of proteasome inhibition on cell growth and viability, both untreated and MG132-treated (20 h) LLC-MK2 and A549 cells were stained with trypan blue and DAPI followed by visual inspection under a microscope ( Fig. 2A-D' ). The presence of MG132 did not significantly inhibit the cell viability or alter the cell morphology (compare Fig. 2A 
Different contribution of the UPS to the modulation of stable components of the MT cytoskeleton during influenza A (H1N1) virus infection in LLC-MK2 and A549 cells
Taking into account the fact that proteasome inhibition during late stages of influenza A virus infection has negative effects on influenza virus replication, we investigated how it influences the expression of markers for stable MTs in LLC-MK2 and A549 cells infected by influenza A (H1N1) virus. With this aim, the cells were first infected by influenza A virus (MOI = 1 PFU/cell; 24 h) and at 4 h p.i. either mock-treated or MG132-treated for the remaining infectious period. At 24 h p.i. the relative levels of acetylated alpha-tubulin and MAP4 were estimated using Western blot analysis (Fig. 3) . As it has been already described (see above and Fig. 1 ), in mock-infected LLC-MK2 cells the long-term exposure to MG132 caused a slight increase in the level of acetylated alpha-tubulin and a slight decrease in the level of MAP4 (lane 2 vs lane 1 in Fig. 3A and B) . Viral infection caused a decrease in the levels of both acetylated alpha-tubulin and MAP4, which were partially regained as a result of proteasome activity inhibition by MG132. However, in no case did the level of acetylated alphatubulin reach the value observed in non-infected cells treated with MG132. In A549 cells, acetylated alpha-tubulin and MAP4 were barely expressed. Perhaps because of these low levels, no obvious trend in reaction to either viral infection or MG132 treatment was revealed with the exception of an increase in the level of MAP4 as a result of both viral infection and MG132 treatment (lane 4 vs 3 and lane 6 vs 5 in Fig. 3B') . 1, 3, 5 ) or MG132-treated (8 μM) (lanes 2, 4, 6), without drug removal for the remaining period (4-24 h p.i.). Cells were then harvested and equivalent amounts of homogenates analysed by immunoblotting with antibodies against acetylated alpha-tubulin (A, A') and MAP4 (B, B'). C, C' -The presence of GAPDH was checked in parallel as a protein loading control. D, D' -Relative intensity values from three independent experiments repeated in two replicate wells were first normalized to GAPDH and then analysed regarding density differences with corresponding control samples. Error bars in graphs correspond to standard deviations. ** P < 0.005, * P < 0.05, and n.s. P > 0.05 vs the corresponding control groups, as determined by two-tailed Student's t-test. E, E' -IIF assays for NP expression in MDCK cells inoculated for 24 h with culture supernatants (SPN) harvested at 24 h p.i. from LLC-MK2 (E) and A549 (E') cell monolayers used for Western blotting assays. IIF images were collected with a conventional fluorescence microscope (magnification: 200x).
Fig. 4. Proteasome activation differently modulates MT stabilization in LLC-MK2 and A549 cells. A-C -LLC-MK2 and A'-C' -A549 cells were either kept mock-treated (NT)
or IU1-treated (50 μM) (IU1) for the indicated times. Cells were then harvested and equivalent amounts of homogenates analysed by immunoblotting with antibodies against acetylated alpha-tubulin (A, A') and MAP4 (B, B'). C, C' -The presence of GAPDH was checked in parallel as a protein loading control. D, D' -Relative intensity values from three independent experiments repeated in two replicate wells were first normalized to GAPDH and then analysed regarding density differences with corresponding control samples. Error bars in graphs correspond to standard deviations. ** P < 0.005 and n.s. P > 0.05 vs the corresponding control groups, as determined by two-tailed Student's t-test.
To control the persistence of virus replication in the influenza A virus-infected LLC-MK2 and A549 cell monolayers studied in the above-described experiments, the culture supernatants were harvested at 24 h p.i. and then inoculated in MDCK cells for 24 h before IIF staining with anti-NP antibodies. The results (Fig. 3E and E' ) confirmed the presence of infectious viruses in the culture supernatants used for the inoculation of MDCK cells.
Proteasome activation with IU1 improves the dynamic state of the MT cytoskeleton in LLC-MK2 cells
In order to gain more insight into the contribution of proteasomes to the regulation of MT dynamics in the cell models studied, we evaluated whether the levels of stable MT cytoskeleton markers are influenced by an activator of the UPS, IU1, that inhibits the deubiquitinating enzyme USP14 and for this reason increases the degradation of proteins by proteasomes [28] . To this purpose, LLC-MK2 and A549 cells were treated for different time periods (from 4 h to 8 h) with IU1 followed by Western blotting analysis of the levels of markers for MT stabilization (Fig. 4) . The results demonstrate that in LLC-MK2 cells acetylated alpha-tubulin is down-regulated upon proteasome activation for 4-8 h (Fig. 4A) , while MAP4 remains almost unaffected (Fig. 4B) . In A549 cells the IU1 treatment did not have any effect on expression levels of either acetylated alphatubulin or MAP4 despite their low expression in untreated cells (Fig. 4A' and B' ). Taking Fig. 5C and Fig. 5D , respectively, evidence that proteasome activation improves virus replication also in A549 cells, although less prominently than in LLC-MK2 cells. Values represent the mean of three independent experiments repeated in two replicate shell vials. Error bars in graphs correspond to standard deviations. ** P < 0.005, * P < 0.05, and n.s. P > 0.05 vs the corresponding control groups, as determined by two-tailed Student's t-test.
Proteasome activation with IU1 improves influenza A (H1N1) virus growth in LLC-MK2 and A549 cells
The influenza virus nucleoprotein partially co-localizes with 20S proteasomes in influenza A (H1N1) virus-infected LLC-MK2 cells
Taking into consideration the fact that contribution of the UPS to the control of the MT cytoskeleton dynamics was much more evident in LLC-MK2 than in A549 cells, only LLC-MK2 cells were studied in further experiments. We compared the cellular distribution of 20S proteasomes and viral NP in LLC-MK2 cells. To this purpose, the cells were infected with either influenza A/NWS/33 or A/Mallard/03 virus strain (MOI = 2 PFU/cell; 14 h) and then IIF staining of 20S proteasomes and viral NP was performed, followed by confocal microscopy analysis. Accordingly to previous studies [35, 36] , 20S proteasomes showed diffuse staining and were present both in nuclei and cytoplasm ( Fig. 6A and B) . The influenza virus NP was primarily located in the cytoplasm, where a "dot-like" staining pattern was observed (Fig. 6A1 and B1 ). In Fig. 6A2 and B2 , partial colocalization of NP and 20S proteasomes was observed at least in the case of Representative micrographs from single focal planes are shown. A2, B2 -The areas of co-localization (orange/yellow) are indicated by superposition of the two signals; no co-localizing areas maintain the original colours (green, 20S proteasomes; red, viral NP). A3, B3 -Scatter diagrams generated from the merged images A2 and B2, respectively, outlining the pixelto-pixel correlation between the red and green channels. The Zeiss LSM 510 meta software was used to measure the weighted co-localization coefficients (green channel: Ch2-T1; red channel: Ch3-T2). A4, B4 -The line scan graphs show the profiles of signal distribution of 20S proteasomes and viral NP along the freely positioned arrows in A2 and B2, respectively. Results are representative of two independent experiments repeated in two replicate shell vials. Scale bar = 10 μm.
LLC-MK2 cells infected by influenza A/NWS/33 strain (see scatter diagrams in Fig. 6A3 and B3 and line scan graphs showing the profiles of signal distribution in Fig. 6A4 and B4 ).
20S proteasomes localize on stable MTs during influenza A (H1N1) virus infection in LLC-MK2 cells
In the next set of experiments we compared the subcellular distribution of 20S proteasomes and markers for stabilized MTs (acetylated alpha-tubulin and MAP4) in LLC-MK2 cells infected for 14 h with influenza A virus (either A/NWS/33 or A/Mallard/03 inoculated at an MOI of 2 PFU/cell). The chosen period of infection allowed us to better carry out analyses at a subcellular level, avoiding consistent MT cytoskeleton/cell morphology reorganization, which is more easily detectable at later times of the infectious process (not shown). The mock-infected cells were studied as a control. The results of immunostaining (representative confocal sections and graphs demonstrating profiles of signal distribution) are shown in Figs 7 and 8. Partial co-localization of proteasomes with acetylated alpha-tubulin was observed in both mock-infected and infected cells (see Fig. 7A2 , B2 and C2 and scatter diagrams in Fig. 7A3, B3 and C3) . In infected cells, the acetylated alpha-tubulin networks became thickened and predominantly condensed in the perinuclear area, especially in the case of infection by A/NWS/33 strain (arrowheads in Fig. 7B1 and C1 ). It is in these areas that co-localization of 20S proteasomes and acetylated alpha-tubulin was especially evident (see arrowheads in Fig. 7B2 and C2, and line scan graphs showing the profiles of signal distribution in Fig. 7B4 and C4 ). The MAP4 labelling was weaker in influenza virus-infected than in mock-infected LLC-MK2 cells ( Fig. 8B1 and C1 vs Fig. 8A1 ), in agreement with our previous observation [12] . Moreover, the co-localization between alpha 1/p27 proteasome subunit and MAP4 prevalently noticed in the perinuclear area of mock-infected cells (arrowheads in Fig. 8A2 ) was extended to a wider cytoplasmic area upon virus infection (Fig. 8A2 vs Fig. 8B2 and Fig. 8C2 ). proteasomes; red, acetylated alpha-tubulin). A3, B3, C3 -Scatter diagrams generated from the merged images A2, B2, and C2, respectively, outlining the pixel-to-pixel correlation between the red and green channels. The Zeiss LSM 510 meta software was used to measure the weighted co-localization coefficients (green channel: Ch2-T1; red channel: Ch3-T2). A4, B4, C4 -The line scan graphs show the profiles of signal distribution of 20S proteasomes and acetylated alpha-tubulin along the freely positioned arrows in A2, B2, and C2, respectively. Results are representative of two independent experiments repeated in two replicate shell vials. Scale bar = 10 μm. no co-localizing areas maintain the original colours (red, alpha 1/p27 proteasome subunit; green, MAP4). A3, B3, C3 -Scatter diagrams generated from the merged images A2, B2, and C2, respectively, outlining the pixel-to-pixel correlation between the red and green channels. The Zeiss LSM 510 meta software was used to measure the weighted colocalization coefficients (green channel: Ch2-T1; red channel: Ch3-T2). A4, B4, C4 -The line scan graphs show the profiles of signal distribution of 20S proteasomes and MAP4 along the freely positioned arrows in A2, B2, and C2, respectively. Results are representative of two independent reproducible experiments repeated in two replicate shell vials. Scale bar = 10 μm.
DISCUSSION
The MT cytoskeleton undergoes polymerization and depolymerization in response to different signals. This particular behaviour is at the basis of the so-called MT dynamic instability. The MT dynamics are controlled in different ways, including the intervention of proteasomes [37, 38] . Although it is known that viruses may modify MT networks [3, [39] [40] [41] , the particular mechanisms remain obscure. Here we investigated the relationship between pharmacological interference with proteasome-dependent proteolysis and modulation of stable MT cytoskeleton during the replication cycle of two (human and avian) influenza A (H1N1) viruses in LLC-MK2 and A549 cells. We previously demonstrated the presence of restriction mechanisms against influenza A virus infection in LLC-MK2 cells, which operated at the level of cytoskeleton dynamics [12, 26, 27] . Thus, we expected that this cellular model can be successfully employed to study the mechanisms controlling the cytoskeleton dynamics in the course of cell infection with influenza virus. The other cellular model (A549 cells) was used to check the generality of observations made on LLC-MK2 cells. The results presented here suggest that the UPS system may be involved in modification (destabilization) of the MT cytoskeleton in cells infected by influenza A virus. The decrease of the level of acetylated alphatubulin (indicative of mobilization of the MT cytoskeleton) in influenza A virusinfected cells was partially reversed by prolonged proteasome inhibition with MG132. Although our previous findings [12] principally envisaged the recruitment of proteasomes for mobilization of stable MTs in the course of influenza virus replication, we did not address this possibility by direct experiments. Here we have demonstrated that the increase of acetylated alphatubulin (indicative of stabilization of the MT cytoskeleton), caused by long-term incubation of cells with the proteasome inhibitor MG132, correlates with partial suppression of influenza A virus replication. Importantly, cell viability and growth are known to be unaffected by exposure to MG132 for 10-20 h [42] . Moreover, the efficacy of MG132 in LLC-MK2 and A549 cells was previously assessed [43] [44] [45] [46] . In MG132-treated and infected LLC-MK2 cells we observed weaker NP cytoplasmic labelling, supporting the hypothesis of nuclear/cytoplasmic MTmediated viral shuttling impairment. Accordingly, other authors [47] [48] [49] demonstrated that proteasome inhibition affects MT dynamics and related transport mechanisms. Although viral infection negatively interfered with the expression of stable components of MTs in LLC-MK2, conflicting results in A549 cells suggested that in this cellular model influenza A viruses take advantage of increased MT stabilization during late phases of replication. Similar conclusions were previously drawn for influenza virus-infected MDCK cells [12, 50] . In any case, the different effects observed upon proteasome inhibition in influenza A virus-infected LLC-MK2 and A549 cells could be explained by initial differences in the state of MT polymerization in these cells.
These cellular models also reacted differently to the activator of the UPS (IU1). Although, in LLC-MK2 cells treated with IU1, the level of acetylated alpha-tubulin decreased, it remained low but unchanged in A549 cells. Interestingly, we found that influenza A virus replication in LLC-MK2 cells was enhanced upon proteasome activation, which may be due to the increased MT cytoskeleton dynamics. Moreover, even in A549 cells influenza A virus growth was improved upon stimulation of the UPS, although in a less prominent way than in LLC-MK2 cells. In view of the apparent involvement of the UPS in control of MT dynamics in influenza virus-infected LLC-MK2 cells, we analysed the mutual distribution of 20S proteasomes and markers of polymerized MTs in these cells. Using IIF and confocal microscopy we demonstrated (i) partial juxtaposition of viral NP with 20S proteasomes and (ii) partial co-localization of stable MT cytoskeleton markers with 20S proteasomes. Although the latter was observed in both control and infected cells, the distribution of acetylated alpha-tubulin and MAP4 changed as a result of virus infection. The perinuclear thickening of acetylated alpha-tubulin networks and the decrease of MAP4 expression observed in infected LLC-MK2 cells were suggestive of virus-induced modulation of stable components of MTs. Moreover, the different subcellular distribution of colocalization signals between 20S proteasomes and each examined marker for stabilized MTs suggested that in infected LLC-MK2 cells proteasomes might form complexes with stable MTs through selective interactions with either acetylated alpha-tubulin or MAP4. Taken together, the observations presented suggest that proteasomes may differently influence the properties of the MT cytoskeleton in influenza A virusinfected cells, depending on the specific properties of both the host cell line and the virus strain. Influenza A virus might take selective advantage of proteasome functions in order to set up a favourable cytoskeletal "environment" for its replication and spread. However, our findings suggest that the relationship between influenza virus and the host cell is quite complex and depends on many factors, which makes it difficult to generalize the obtained conclusions. Although our findings support a proposal that UPS functions favour late stages of influenza virus infection in LLC-MK2 cells via preventing MT stabilization and promoting MT-mediated intracellular trafficking, we cannot exclude that the involvement of proteasomes is another way for influenza viruses to shut off or modify MT-related signalling pathways, which might be central to innate immune defence but may also indirectly contribute to virus virulence [3, 51] . Taking into consideration the fact that proteasomes play an important role in regulation of many cellular processes, one cannot rule out a possibility that the alteration of protein homeostasis induced upon proteasome inhibition affects influenza virus infection through MT-independent pathways. To this end, it has been shown that the activation of the proinflammatory nuclear factor k-B (NF-kB), which is considered a hallmark of efficient influenza A virus replication [52] [53] [54] , is strictly linked to the proteasomal degradation of the inhibitory proteins of kB (IkBs) [55] . Of note, an inhibitory effect on the NF-kB pathway through suppression of the IkBs proteasome-mediated degradation has been observed in different cell lines [56] [57] [58] . Furthermore, it has been reported that the proteasome inhibitor PS-341 impairs influenza A virus propagation in different cells via the activation of both NF-kB and c-Jun NH 2 -terminal kinase (JKN) pathways as well as upregulating the transcription of antivirus-acting cytokines, such as IL-6, IL-8 and CCL/RANTES [59] . Finally, it has been found that proteasome inhibition in influenza A virus-infected cells restores the levels of the transcription factor Sp1 and copper-zinc superoxide dismutase 1 [60] , affecting the generation of reactive oxygen species and activation of specific oxidative stress-sensitive signalling pathways implicated in viral pathogenesis [61, 62] . Thus, further studies are necessary to better dissect the multifaceted relationship between influenza virus and the MT cytoskeleton and shed light on potential antiviral targets.
